DOSE SELECTION FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS

Traditionally , carcinogenicity studies for chemical agents have relied upon the maximally tolerated dose ( MTD ) as the standard method for high dose selection ( Note.Additional pharmaceutical-specific endpoints to select an appropriate high dose are currently under discussion ( e . g . , additional pharmacodynamic , pharmacokinetic and toxicity endpoints as well as alternatives to a maximum feasible dose ) .